| 書(shū)目名稱(chēng) | Purinergic and Pyrimidinergic Signalling II |
| 副標(biāo)題 | Cardiovascular, Resp |
| 編輯 | Maria Pia Abbracchio,Michael Williams |
| 視頻video | http://file.papertrans.cn/765/764115/764115.mp4 |
| 概述 | This two-part volume is an update and objective state of the art of the current knowledge in the field, with particular emphasis on the development of novel therapeutic entities that may prove useful |
| 叢書(shū)名稱(chēng) | Handbook of Experimental Pharmacology |
| 圖書(shū)封面 |  |
| 描述 | Physiological, pharmacological and molecular biological data generated over the past three decades have demonstrated the existence of two major families of extracellular receptors, the P1, a family of four G-protein coupled receptors and the P2, a family of at least 12 receptors responsive to purine (ATP, ADP) and pyrimidine (UTP) nucleotides through which adenosine and ATP can function as extracellular messengers. The present two-part volume represents an integrated compendium of invited chapters by leading researchers in the area focusing on advances in the understanding of purinergic and pyrimidinergic signaling systems, their role(s) in tissue function and pathophysiology and advances in developing potential new medications based on the modulation of P1 and P2 receptor signaling processes. The volumes will thus provide the reader with a topical, comprehensive and integrated overview of this important area. |
| 出版日期 | Book 2001 |
| 關(guān)鍵詞 | Diabetes; Pathophysiologie; Purine; Purines; Pyrimidine; adenosine; bone; endothelium; entities; new therapeu |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-642-56921-0 |
| isbn_softcover | 978-3-642-63223-5 |
| isbn_ebook | 978-3-642-56921-0Series ISSN 0171-2004 Series E-ISSN 1865-0325 |
| issn_series | 0171-2004 |
| copyright | Springer-Verlag Berlin Heidelberg 2001 |
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2026-1-25 10:31
發(fā)表于 2025-3-21 19:33:17
